Volume 97, Issue 1 pp. 127-129

Catecholaminergic polymorphic ventricular tachycardia in a child: A case report

Lara Garabedian

Lara Garabedian

Department of Pediatric Cardiology, University Hospital Gent, Belgium

Search for more papers by this author
Ann Verryckt

Ann Verryckt

Department of Pediatric Cardiology, University Hospital Gent, Belgium

Search for more papers by this author
Joseph Panzer

Joseph Panzer

Department of Pediatric Cardiology, University Hospital Gent, Belgium

Search for more papers by this author
Daniel De Wolf

Daniel De Wolf

Department of Pediatric Cardiology, University Hospital Gent, Belgium

Search for more papers by this author
First published: 11 December 2007
Citations: 1
Correspondence
Daniel De Wolf, MD, PhD, Department of Pediatric Cardiology, Kliniek voor Kinderziekten ‘C. Hooft’, University Hospital Gent, 1K5 De Pintelaan 185, B-9000 Gent, Belgium. Tel: +32 9 240 24 64 | Fax: +39 9 240 58 56 Email: [email protected]

Abstract

Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare arrythmogenic disease characterized by exercise – or stress – induced ventricular tachyarryhtmias, syncope, or sudden death, usually in the pediatric age group. Familial occurrence has been noted in about 30% of cases. Inheritance may be autosomal dominant or recessive, usually with high penetrance. The causative genes have been mapped to chromosome 1. Mutations of the cardiac ryanodine receptor gene (RyR2) have been identified in autosomal dominant pedigrees, while calsequestrin gene (CASQ2) mutations are seen in recessive cases.

Conclusion: Due to its potential lethal outcome, exclusion or confirmation of catecholaminergic polymorphic ventricular tachycardia in children with physical and emotional syncope is mandatory. We report a case of catecholaminergic polymorphic ventricular tachycardia in a three-year-old child only diagnosed by genetic mapping.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.